Productivity cost calculations in health economic evaluations: Correcting for compensation mechanisms and multiplier effects

Social Science and Medicine

Volumn 75, Issue 11, 2012, Pages 1981-1988

  Krol, Marieke ^a   Brouwer, Werner B F ^a   Severens, Johan L ^a   Kaper, Janneke ^b   Evers, Silvia M A A ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Absenteeism; Compensation mechanisms; Economic evaluation; Methodology; NLD; Productivity costs; Team dependency

Indexed keywords

COST; ECONOMICS; HEALTH CARE; METHODOLOGY; PRODUCTIVITY;

ABSENTEEISM; ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; DUTCH; ECONOMIC EVALUATION; ETHNIC GROUP; FEMALE; FINANCIAL MANAGEMENT; HUMAN; MALE; MEDICAL LITERATURE; NORMAL HUMAN; PRODUCTIVITY; QUESTIONNAIRE; REIMBURSEMENT; SALARY; SMOKING CESSATION; WORK SCHEDULE; WORKMAN COMPENSATION;

ABSENTEEISM; ADULT; COST-BENEFIT ANALYSIS; EFFICIENCY; EMPIRICAL RESEARCH; EMPLOYMENT; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; SICK LEAVE; SMOKING CESSATION;

EID: 84866917908     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2012.07.012     Document Type: Article

References (29)

1. Brouwer W.B.F., Exel J.A., Baltussen R.M.P.M., Rutten F.F.H. A dollar is a dollar - or is it?. Value in Health 2006, 9(5):341-347.
2. Brouwer W.B., Koopmanschap M.A., Rutten F.F. Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion. Health Economics 1997, 6(5):511-514.
3. Claxton K., Paulden M., Gravelle H., Brouwer W.B.F., Culyer A.J. Discounting and decision making in the economic evaluation of health care technologies. Health Economics 2011, 20(1):2-15.
4. Drummond M., Barbieri M., Cook J., Glick H.A., Lis J., Malik F., et al. Transferability of economic evaluations across jurisdictions: ISPOR good research practices task force report. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research 2009, 12(4):409-418.
5. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., Stoddart G.L. Methods for the economic evaluation of health care programmes (3rd ed.). Oxford/New York: Oxford Medical Publications/Oxford University Press 2005.
6. Gold M., Siegel J., Russell L., Weinstein M. Cost-effectiveness in health and medicine 1996, Oxford University Press, Oxford.
7. Hakkaart-van Rooijen L., Tan S.S., Bouwmans C.A.M. Dutch costing manual 2010, Institute for Medical Technology Assessment, Rotterdam, (by order of the Board of Health Insurances).
8. Jacob-Tacken K.H., Koopmanschap M.A., Meerding W.J., Severens J.L. Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes. Health Economics 2005, 14(5):435-443.
9. Johannesson M. A note on the depreciation of the societal perspective in economic evaluation of health care. Health Policy (Amsterdam, Netherlands) 1995, 33(1):59-66.
10. Jonsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. The European Journal of Health Economics: HEPAC: Health Economics in Prevention and Care 2009, 10(4):357-359.
11. Kaper J., Wagena E.J., Willemsen M.C., van Schayck C.P. Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction (Abingdon, England) 2005, 100(7):1012-1020.
12. Karasek R.A. Job demands, job decision latitude, and mental strain: implications for job redesign. Administrative Science Quarterly 1979, 24(June):285-308.
13. Knies S., Severens J.L., Ament A.J., Evers S.M. The transferability of valuing lost productivity across jurisdictions. Differences between national pharmacoeconomic guidelines. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research 2010, 13(5):519-527.
14. Koopmanschap M.A. PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies. Expert Review of Pharmacoeconomics & Outcomes Research 2005, 5(1):23-28.
15. Koopmanschap M.A., van Ineveld B.M. Towards a new approach for estimating indirect costs of disease. Social Science & Medicine 1992, 34(9):1005-1010. (1982).
16. Koopmanschap M.A., Rutten F.F. Indirect costs in economic studies: confronting the confusion. PharmacoEconomics 1993, 4(6):446-454.
17. Koopmanschap M.A., Rutten F.F. The impact of indirect costs on outcomes of health care programs. Health Economics 1994, 3(6):385-393.
18. Koopmanschap M.A., Rutten F.F., van Ineveld B.M., van Roijen L. The friction cost method for measuring indirect costs of disease. Journal of Health Economics 1995, 14(2):171-189.
19. Krol M., Papenburg J., Koopmanschap M., Brouwer W. Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders. PharmacoEconomics 2011, 29(7):601-619.
20. Nicholson S., Pauly M.V., Polsky D., Sharda C., Szrek H., Berger M.L. Measuring the effects of work loss on productivity with team production. Health Economics 2006, 15(2):111-123.
21. Olsen J., Richardson J. Production gains from health care: What should be included in cost-effectiveness analysis. Social Science and Medicine 1999, 49(1):17-26.
22. Pauly M.V., Nicholson S., Polsky D., Berger M.L., Sharda C. Valuing reductions in on-the-job illness: 'presenteeism' from managerial and economic perspectives. Health Economics 2008, 17(4):469-485.
23. Pauly M.V., Nicholson S., Xu J., Polsky D., Danzon P.M., Murray J.F., et al. A general model of the impact of absenteeism on employers and employees. Health Economics 2002, 11(3):221-231.
24. Pritchard C., Sculpher M. Productivity costs: Principles and practice in economic evaluation 2000, Office of Health Economics, London.
25. Rodenburg-van Dieten H.E.M. Richtlijnen Voor Farmaco-Economisch Onderzoek; Evaluatie En Actualisatie 2005, College voor zorgverzekeringen, Diemen.
26. Severens J.L., Laheij R.J., Jansen J.B., Van der Lisdonk E.H., Verbeek A.L. Estimating the cost of lost productivity in dyspepsia. Alimentary Pharmacology & Therapeutics 1998, 12(9):919-923.
27. Tranmer J.E., Guerriere D.N., Ungar W.J., Coyte P.C. Valuing patient and caregiver time: a review of the literature. PharmacoEconomics 2005, 23(5):449-459.
28. Williams A. Cost-effectiveness analysis: is it ethical?. Journal of Medical Ethics 1992, 18(1):7-11.
29. Zhang W., Bansback N., Boonen A., Severens J.L., Anis A.H. Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis. Value in Health: The Journal of the International Society for Pharmacoeconomics and Outcomes Research 2012, 15(1):46-54.